CClinicalTrials.gg
CompletedNCT00619632BINGOUpdated Jan 14, 2015

Boosting Breastfeeding in Low-Income, Multi-ethnic Women: A Primary Care Based RCT

An interventional study of Lactation Consultant and Provider Prompt in Breastfeeding and Breastfeeding, Exclusive, sponsored by Albert Einstein College of Medicine. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-14.

Sponsored by Albert Einstein College of Medicine · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
666
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This is a randomized, controlled, single-center, single-blind, 2x2 factorial design trial of routine provider, primary care-based interventions to increase breastfeeding intensity up to 6 months in low-income multiethnic women, with stratification for maternal country of birth. The Best Infant Nutrition for Good Outcomes (BINGO) trial will randomize women into one of four treatment groups: (a) Prenatal Care Provider (PNC); (b) Lactation Consultant (LC); (c) PNC + LC, or; (d) Control. Thus, the separate and synergistic effects of the interventions will be tested, compared to a Control standard of care. The intervention and design build upon our prior trial of an LC intervention alone.

PNCs- certified nurse midwives and ob/gyns-- will use a brief, electronically prompted protocol with women in the PNC, and PNC + LC groups throughout pregnancy. An LC will arrange pre-natal one-on-one meetings, daily hospital, and home visits with women in the LC and PNC+LC groups. Descriptive data on infant health visits, and participant/provider experiences will be collected as secondary outcomes. Interviews at 1,3 and 6 months post-partum will collect infant feeding, and health visit data outside the medical center. Medical center visit data will be obtained from MIS data.

Primary Outcomes (Hypotheses): Breastfeeding

  1. Breastfeeding Intensity at 1,3, and 6 Months
  2. Exclusive Breastfeeding at 1,3, and 6 Months

    Secondary Outcomes (Descriptive): Infant Health, and Participant/Provider Experience

  3. To describe the frequency and timing of infant health visits for "breast-feeding sensitive" illnesses
  4. To describe participant and provider (LC and PNC) experience of the interventions.
Read the detailed description

Primary Outcomes (Hypotheses): Breastfeeding

  1. Breastfeeding Intensity at 1,3, and 6 Months- There will be significant differences in breastfeeding intensity among the 4 treatment groups. We expect that intensity will be greatest in the PNC+LC group, followed by the LC, then the PNC, and Control groups, respectively. Intensity will be assessed via 7 day recall of the frequency of breastmilk feedings vs. other liquids and solids.
  2. Exclusive Breastfeeding at 1,3, and 6 Months- There will be significant differences in the rate of exclusive breastfeeding among the 4 treatment groups. We expect that rates of exclusive breastfeeding will be greatest in the PNC+LC group, followed by the LC, then the PNC, and Control groups, respectively.

    Secondary Outcomes (Descriptive): Infant Health, and Participant/Provider Experience

  3. To describe the frequency and timing of infant health visits for "breast-feeding sensitive" illnesses (i.e., otitis media, gastrointestinal, and respiratory infections) by treatment group.
  4. To describe the frequency and timing of infant health visits for "breast-feeding sensitive" illnesses by intensity of breastfeeding regardless of group assignment.
  5. To describe participant and provider (LC and PNC) experience of the interventions.

BINGO is the first RCT in the US of routine provider, primary-care based interventions to increase breastfeeding (BF). Government task forces in the US3 and Canada specifically call for such trials, as well as trials to assess independent effects of combined interventions. BINGO is the first trial to apply strategies derived from the current National Breastfeeding Awareness Campaign (NBAC). BINGO will employ the NBAC message-- that exclusive BF for 6 months reduces infant ear infections, diarrhea, respiratory illness, and perhaps childhood obesity. We expect this message will yield greater BF intensity, and thus progress toward pending Healthy People 2010 goals for exclusive BF.

BINGO uses evidence-based strategies in practice, consistent with the NIH roadmap. Its interventions are logistically and economically sustainable in clinical practice. They support women pre- and post-natally, across multiple care settings (clinic, hospital, home). Both Certified Nurse Midwives and Ob/Gyns, deliver the PNC intervention, thus increasing generalizability. BINGO now has the enthusiastic support of perinatal nursing, physician, and lactation specialist groups. This support, at the outset, provides the foundation for effective BINGO interventions to be translated into practice.

02

Conditions studied

  • Breastfeeding
  • Breastfeeding, Exclusive
03

In context

Lead sponsor

Albert Einstein College of Medicine is the lead sponsor of 199 studies on the registry; 21 are open to participants now.

Of its 44 completed or terminated interventional studies of FDA-regulated products, 35 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Enrolled/plan to remain in care at the site throughout their pregnancy
  • 1st or 2nd trimester (randomization will include trimester as a blocking factor)
  • Aged 18 or older
  • Can provide a reliable phone number and at least 2 alternative contacts
  • Are carrying a singleton pregnancy
  • Can communicate in English or Spanish

Exclusion criteria

Exclusion Criteria:

  • High risk of prematurity/NICU (e.g., ESRD, multiple prior preterms, congenital anomalies)
  • Medical/obstetrical complications for which BF is or may be perceived to be contra-indicated (e.g., HIV+, HTLV-1, breast reduction surgery, Hepatitis B and C, pre-gestational diabetes )
  • On chronic medications incompatible with BF (e.g., hypoglycemics, lithium, ciprofloxacin)
  • Enrolled in site's Group Pre-natal Care (app. 60 women/year)
  • Previously enrolled in MILK study
  • Craniofacial or neurological conditions that prevent an infant from BF (post-partum exclusion)
  • Reported use of street drugs (responds to reviewer comment of how to control for this)
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
666 participants (actual)

Study arms

  • Experimental
    1

    LC- Primary-care based lactation consultant meeting women pre- and post-natally.

    Behavioral: Lactation Consultant

  • Experimental
    2

    Provider Prompt

    Behavioral: Provider Prompt

  • Experimental
    3

    LC+Provider Prompt

    Behavioral: LC+ Provider Prompt

  • No intervention
    Control

Interventions

  • BehavioralLactation Consultant

    Lactation consultant- primary care based, meets with women pre-natally, in the hospital, and at home up to 6 months post-partum.

  • BehavioralProvider Prompt

    Prompt in electronic prenatal record will appear 5 times throughout pregnancy re: up to 10 open-ended discussion points for provider to raise

  • BehavioralLC+ Provider Prompt

    Participants in this group receive both the LC and Provider Prompt interventions.

06

What researchers measure

Primary outcomes

  1. Breastfeeding duration and intensity

    Time frame: Assessed at 1,3, and 6 months

Secondary outcomes

  1. Infant health visits

    Time frame: 12 months

  2. Patient and provider experiences of the interventions

    Time frame: 6 months

07

Study locations

1 site
  • Comprehensive Family Care Center
    Bronx, New York 10461, United States
08

References and documents

Publications

  • Bonuck K, Stuebe A, Barnett J, Labbok MH, Fletcher J, Bernstein PS. Effect of primary care intervention on breastfeeding duration and intensity. Am J Public Health. 2014 Feb;104 Suppl 1(Suppl 1):S119-27. doi: 10.2105/AJPH.2013.301360. Epub 2013 Dec 19. PubMed 24354834 ↗
  • Andaya E, Bonuck K, Barnett J, Lischewski-Goel J. Perceptions of primary care-based breastfeeding promotion interventions: qualitative analysis of randomized controlled trial participant interviews. Breastfeed Med. 2012 Dec;7(6):417-22. doi: 10.1089/bfm.2011.0151. Epub 2012 May 23. PubMed 22621223 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00619632
Lead sponsor
Albert Einstein College of Medicine
Collaborators
Montefiore Medical Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Karen Bonuck (PI, Albert Einstein College of Medicine) — Principal investigator
First posted
Feb 21, 2008
Start date
Feb 2008
Primary completion
Feb 2013
Completion
Feb 2013
Last update
Jan 14, 2015

Study contacts

Karen A. Bonuck, PhD
principal investigator · Albert Einstein College of Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion